| Current assets: |
| Cash and cash equivalents |
130.58M |
| Short-term investments |
144.63M |
| Trade accounts receivable |
39.11M |
| Inventory |
89.54M |
| Prepaid antigen costs |
| Prepaid expenses and other current assets |
| Total current assets |
425.97M |
| Property and equipment, net |
144.13M |
| Long-term investments |
62.06M |
| Other assets |
6.79M |
| Total assets |
638.95M |
| Current liabilities: |
| Accounts payable |
13.37M |
| Accrued liabilities |
42.37M |
| Accrued compensation |
19.87M |
| Convertible senior notes due 2016 |
| Current portion of capital lease obligations |
2.69M |
| Current portion of facility lease obligations |
621K |
| Total current liabilities |
86.66M |
| Long-term accrued liabilities |
5.16M |
| Capital lease obligations, less current portion |
5.57M |
| Facility lease obligations, less current portion |
10.64M |
| Convertible senior subordinated notes due 2014 |
27.69M |
| Commitments and contingencies (Note 10) |
| Stockholders' equity: |
| Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding |
0 |
| Common stock, $0.001 par value; 250,000,000 shares authorized, 148,866,750 and 147,447,208 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
152K |
| Additional paid-in capital |
1.99B |
| Accumulated other comprehensive income |
91K |
| Accumulated deficit |
-2.03B |
| Total stockholders' equity |
-35.91M |
| Total liabilities and stockholders' equity |
638.95M |
